291 related articles for article (PubMed ID: 20856196)
41. Modulation of the 5'-deoxyribose-5-phosphate lyase and DNA synthesis activities of mammalian DNA polymerase beta by apurinic/apyrimidinic endonuclease 1.
Wong D; Demple B
J Biol Chem; 2004 Jun; 279(24):25268-75. PubMed ID: 15078879
[TBL] [Abstract][Full Text] [Related]
42. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.
Boyerinas B; Park SM; Murmann AE; Gwin K; Montag AG; Zillhardt M; Hua YJ; Lengyel E; Peter ME
Int J Cancer; 2012 Apr; 130(8):1787-97. PubMed ID: 21618519
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional coactivators CBP and p300 cooperatively enhance HNF-1alpha-mediated expression of the albumin gene in hepatocytes.
Dohda T; Kaneoka H; Inayoshi Y; Kamihira M; Miyake K; Iijima S
J Biochem; 2004 Sep; 136(3):313-9. PubMed ID: 15598887
[TBL] [Abstract][Full Text] [Related]
44. Comparative Analysis of Quantitative Parameters of Expression of the Retinoic Acid Nuclear Receptor RARα Gene and APE1/YB-1/MDR1 Pattern Genes in Patients with Newly Detected Multiple Myeloma.
Kalitin NN; Chernykh YB; Buravtsova IV
Bull Exp Biol Med; 2017 Nov; 164(1):90-94. PubMed ID: 29119395
[TBL] [Abstract][Full Text] [Related]
45. RNA helicase A in the MEF1 transcription factor complex up-regulates the MDR1 gene in multidrug-resistant cancer cells.
Zhong X; Safa AR
J Biol Chem; 2004 Apr; 279(17):17134-41. PubMed ID: 14769796
[TBL] [Abstract][Full Text] [Related]
46. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
48. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
[TBL] [Abstract][Full Text] [Related]
49. Modulation of the Apurinic/Apyrimidinic Endonuclease Activity of Human APE1 and of Its Natural Polymorphic Variants by Base Excision Repair Proteins.
Kladova OA; Alekseeva IV; Saparbaev M; Fedorova OS; Kuznetsov NA
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998246
[TBL] [Abstract][Full Text] [Related]
50. Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction.
Mantha AK; Dhiman M; Taglialatela G; Perez-Polo RJ; Mitra S
J Neurosci Res; 2012 Jun; 90(6):1230-9. PubMed ID: 22488727
[TBL] [Abstract][Full Text] [Related]
51. The splicing component ISY1 regulates APE1 in base excision repair.
Jaiswal AS; Williamson EA; Srinivasan G; Kong K; Lomelino CL; McKenna R; Walter C; Sung P; Narayan S; Hromas R
DNA Repair (Amst); 2020 Feb; 86():102769. PubMed ID: 31887540
[TBL] [Abstract][Full Text] [Related]
52. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
53. Mechanism of stimulation of DNA binding of the transcription factors by human apurinic/apyrimidinic endonuclease 1, APE1.
Bazlekowa-Karaban M; Prorok P; Baconnais S; Taipakova S; Akishev Z; Zembrzuska D; Popov AV; Endutkin AV; Groisman R; Ishchenko AA; Matkarimov BT; Bissenbaev A; Le Cam E; Zharkov DO; Tudek B; Saparbaev M
DNA Repair (Amst); 2019 Oct; 82():102698. PubMed ID: 31518879
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth.
Fishel ML; He Y; Reed AM; Chin-Sinex H; Hutchins GD; Mendonca MS; Kelley MR
DNA Repair (Amst); 2008 Feb; 7(2):177-86. PubMed ID: 17974506
[TBL] [Abstract][Full Text] [Related]
55. The human apurinic/apyrimidinic endonuclease-1 suppresses activation of poly(adp-ribose) polymerase-1 induced by DNA single strand breaks.
Peddi SR; Chattopadhyay R; Naidu CV; Izumi T
Toxicology; 2006 Jul; 224(1-2):44-55. PubMed ID: 16730871
[TBL] [Abstract][Full Text] [Related]
56. SIRT1 deacetylates APE1 and regulates cellular base excision repair.
Yamamori T; DeRicco J; Naqvi A; Hoffman TA; Mattagajasingh I; Kasuno K; Jung SB; Kim CS; Irani K
Nucleic Acids Res; 2010 Jan; 38(3):832-45. PubMed ID: 19934257
[TBL] [Abstract][Full Text] [Related]
57. Y-Box-Binding Protein 1 Stimulates Abasic Site Cleavage.
Alemasova EE; Naumenko KN; Moor NA; Lavrik OI
Biochemistry (Mosc); 2017 Dec; 82(12):1521-1528. PubMed ID: 29486702
[TBL] [Abstract][Full Text] [Related]
58. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons.
Jiang Y; Guo C; Vasko MR; Kelley MR
Cancer Res; 2008 Aug; 68(15):6425-34. PubMed ID: 18676868
[TBL] [Abstract][Full Text] [Related]
59. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.
Ando K; Hirao S; Kabe Y; Ogura Y; Sato I; Yamaguchi Y; Wada T; Handa H
Nucleic Acids Res; 2008 Aug; 36(13):4327-36. PubMed ID: 18586825
[TBL] [Abstract][Full Text] [Related]
60. Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers.
Poletto M; Di Loreto C; Marasco D; Poletto E; Puglisi F; Damante G; Tell G
Biochem Biophys Res Commun; 2012 Jul; 424(1):34-9. PubMed ID: 22713458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
